Concepedia

Liangqin Guo

LG

21

Publications

678

Citations

16

H-Index

1995

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Liangqin Guo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1995–2020

21

Publications

21

Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2

Lihu Yang, Scott C. Berk, Susan P. Rohrer et al. · Proceedings of the National Academy of Sciences · 1998 · 128 citations · Full text

Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

Qinglin Pu, Hongjun Zhang, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2020 · 82 citations · Full text

Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα

Kevin D. Dykstra, Liangqin Guo, Elizabeth T. Birzin et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 67 citations · Full text

, , +8

Spiro[1<i>H</i>-indene-1,4‘-piperidine] Derivatives As Potent and Selective Non-Peptide Human Somatostatin Receptor Subtype 2 (sst<sub>2</sub>) Agonists

Lihu Yang, Liangqin Guo, Alexander Pasternak et al. · Journal of Medicinal Chemistry · 1998 · 54 citations · Full text

, , +14

Palladium-catalyzed Annulation of Oxygen-Substituted 1,3-Dienes

Richard C. Larock, Liangqin Guo · Synlett · 1995 · 48 citations

, , +9

Rows per page

1–5 of 21